A common E2F-1 and p73 pathway mediates cell death induced by TCR activation

被引:287
作者
Lissy, NA
Davis, PK
Irwin, M
Kaelin, WG
Dowdy, SF [1 ]
机构
[1] Washington Univ, Sch Med, Dept Pathol, Howard Hughes Med Inst, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Med, Howard Hughes Med Inst, St Louis, MO 63110 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA
关键词
D O I
10.1038/35036608
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Strong stimulation of the T-cell receptor (TCR) on cycling peripheral T cells causes their apoptosis by a process called TCR-activation-induced cell death (TCR-AICD)(1-3). TCR-AICD occurs from a late G1 phase cell-cycle check point(4) independently of the 'tumour suppressor' protein p53 (refs 5, 6). Disruption of the gene for the E2F-1 transcription factor(7,8), an inducer of apoptosis(9-11), causes significant increases in T-cell number and splenomegaly(12-15). Here we show that T cells undergoing TCR-AICD induce the p53-related gene p73, another mediator of apoptosis(16), which is hypermethylated in lymphomas(17,18). Introducing a dominant-negative E2F-1 protein or a dominant-negative p73 protein into T cells protects them from TCR-mediated apoptosis, whereas dominant-negative E2F-2, E2F-4 or p53 does not. Furthermore, E2F-1-null or p73-null primary T cells do not undergo TCR-mediated apoptosis either. We conclude that TCR-AICD occurs from a late G1 cell-cycle checkpoint that is dependent on both E2F-1 and p73 activities. These observations indicate that, unlike p53, p73 serves to integrate receptor-mediated apoptotic stimuli.
引用
收藏
页码:642 / 645
页数:5
相关论文
共 30 条
  • [1] ABRAMS SI, 1991, J IMMUNOL, V146, P405
  • [2] Boehme SA, 1996, J IMMUNOL, V156, P4075
  • [3] Corn PG, 1999, CANCER RES, V59, P3352
  • [4] Characterization of the oligomerization defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome
    Davison, TS
    Yin, P
    Nie, E
    Kay, C
    Arrowsmith, CH
    [J]. ONCOGENE, 1998, 17 (05) : 651 - 656
  • [5] Additional complexity in p73:: induction by mitogens in lymphoid cells and identification of two new splicing variants ε and ζ
    De Laurenzi, V
    Catani, MV
    Terrinoni, A
    Corazzari, M
    Melino, G
    Costanzo, A
    Levrero, M
    Knight, RA
    [J]. CELL DEATH AND DIFFERENTIATION, 1999, 6 (05) : 389 - 390
  • [6] Distinct roles for E2F proteins in cell growth control and apoptosis
    DeGregori, J
    Leone, G
    Miron, A
    Jakoi, L
    Nevins, JR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) : 7245 - 7250
  • [7] MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS
    DONEHOWER, LA
    HARVEY, M
    SLAGLE, BL
    MCARTHUR, MJ
    MONTGOMERY, CA
    BUTEL, JS
    BRADLEY, A
    [J]. NATURE, 1992, 356 (6366) : 215 - 221
  • [8] The regulation of E2F by pRB-family proteins
    Dyson, N
    [J]. GENES & DEVELOPMENT, 1998, 12 (15) : 2245 - 2262
  • [9] E2F-1 functions in mice to promote apoptosis and suppress proliferation
    Field, SJ
    Tsai, FY
    Kuo, F
    Zubiaga, AM
    Kaelin, WG
    Livingston, DM
    Orkin, SH
    Greenberg, ME
    [J]. CELL, 1996, 85 (04) : 549 - 561
  • [10] García I, 2000, CELL GROWTH DIFFER, V11, P91